Evidence map›Paper›PMID 29627166›Full record

ReviewLancet (London, England)2018

Equity impacts of price policies to promote healthy behaviours.

Franco Sassi, Annalisa Belloni, Andrew J Mirelman, Marc Suhrcke, Alastair Thomas, Nisreen Salti, Sukumar Vellakkal, Chonlathan Visaruthvong, Barry M Popkin, Rachel Nugent

Abstract readReview
In one paragraph

Review in Lancet (London, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
24.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 155 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 6 countries.

Franco SassiCentre for Health Economics and Policy Innovation, Imperial College Business School, London, UK. Electronic address: f.sassi@imperial.ac.uk.
Annalisa BelloniPublic Health England, London, UK.
Andrew J MirelmanUniversity of York, York, UK.
Marc SuhrckeUniversity of York, York, UK; Luxembourg Institute of Socio-Economic Research, Esch-sur-Alzette, Luxembourg.
Alastair ThomasOrganisation for Economic Co-operation and Development, Paris, France.
Nisreen SaltiAmerican University of Beirut, Beirut, Lebanon.
Sukumar VellakkalBirla Institute of Technology and Science, Pilani, Goa, India.
Chonlathan VisaruthvongMinistry of Finance, Bangkok, Thailand.
Barry M PopkinUniversity of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Rachel NugentResearch Triangle Institute International, Seattle, WA, USA.
American University of Beirut · LBBirla Institute of Technology and Science, Pilani - Goa Campus · INImperial College London · GBLuxembourg Institute of Socio-Economic Research · LUOrganisation de Coopération et de Développement Economiques · FRPublic Health England · GBRTI International · USUniversity of North Carolina at Chapel Hill · USUniversity of York · GB

Funding

Research Services CoreP2CHD050924 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAREN B GUZZO · 2015 to 2026
$9.6M
NICHD NIH HHS P2C HD050924
6 · The paper itself

Abstract

Governments can use fiscal policies to regulate the prices and consumption of potentially unhealthy products. However, policies aimed at reducing consumption by increasing prices, for example by taxation, might impose an unfair financial burden on low-income households. We used data from household expenditure surveys to estimate patterns of expenditure on potentially unhealthy products by socioeconomic status, with a primary focus on low-income and middle-income countries. Price policies affect the consumption and expenditure of a larger number of high-income households than low-income households, and any resulting price increases tend to be financed disproportionately by high-income households. As a share of all household consumption, however, price increases are often a larger financial burden for low-income households than for high-income households, most consistently in the case of tobacco, depending on how much consumption decreases in response to increased prices. Large health benefits often accrue to individual low-income consumers because of their strong response to price changes. The potentially larger financial burden on low-income households created by taxation could be mitigated by a pro-poor use of the generated tax revenues.

Indexed as

Financing, PersonalHealth BehaviorHealth PolicyHealth PromotionHumansSocioeconomic FactorsTaxesTobacco Products

Identifiers

PMID29627166
PMCPMC6642722
OpenAlexW2795611399

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.